Spots Global Cancer Trial Database for biomarkers
Every month we try and update this database with for biomarkers cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma | NCT04499833 | Hepatocellular ... Recurrence Tumo... | liver transplan... | 18 Years - 70 Years | Centro Hospitalar de Lisboa Central | |
| Predicting Prostate Biopsy Results With Biomarkers and mpMRI. | NCT03730324 | Prostate Cancer | mpMRI Urine and plasm... | 18 Years - 75 Years | Odense University Hospital | |
| Prevention of Ovarian Cancer in Women Participating in Mammography | NCT01851109 | Epithelial Ovar... | genetic counsel... | 35 Years - | Fred Hutchinson Cancer Center | |
| Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2 | NCT01837693 | Precancerous Co... Neoplasms | Experimental: i... | 25 Years - 59 Years | Azienda Unità Sanitaria Locale Reggio Emilia | |
| Pilot Study of Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherapy | NCT02494453 | Breast Cancer | Research Cardia... Biomarkers | 18 Years - | University of Michigan Rogel Cancer Center | |
| Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients | NCT04301362 | Cancer Thromboembolism Thrombosis Biomarkers | Thrombosis biom... | 18 Years - | Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. | |
| Analysis of Markers in the Blood Correlated With Neuropathic Pain | NCT02208206 | Neuropathy | 18 Years - | Charite University, Berlin, Germany | ||
| Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome. | NCT04904146 | Mycosis Fungoid... Sezary Syndrome | Blood tests and... | 18 Years - 100 Years | Lund University Hospital | |
| Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer | NCT06341387 | Lung Cancer Non-small Cell ... Non-small Cell ... Lung Cancer Dia... | Breath, urine a... | 50 Years - 80 Years | European Institute of Oncology | |
| Exercise in Women at Risk for Breast Cancer | NCT00092950 | Breast Neoplasm... | Physical activi... | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Florida Pancreas Collaborative Next Generation Biobank | NCT03851133 | Pancreatic Canc... Cancer Cachexia | Blood Sample Co... Tumor Sample co... Data Collection | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| NSABP Biospecimen Discovery Project | NCT01850628 | Breast Cancer | Paclitaxel trastuzumab pertuzumab | 18 Years - | NSABP Foundation Inc | |
| Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors | NCT01081808 | Neoplasms Tumors Solid Tumors Metastatic Canc... | EGFRBi-armed au... | 18 Years - | Roger Williams Medical Center | |
| A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer | NCT00001378 | Breast Cancer Breast Neoplasm... | fenretinide | - | National Institutes of Health Clinical Center (CC) | |
| A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers | NCT02272504 | Cirrhosis Chronic Liver D... | 18 Years - | Wako Life Sciences | ||
| Clinical and Molecular Staging of Lung Cancer Stages I and IIp | NCT03286036 | Lung Cancer | biomarkers | 18 Years - 80 Years | Corporacion Parc Tauli | |
| Mechanisms of Ischemic Stroke in Cancer Patients | NCT02604667 | Stroke Cancer | Blood tests Transcranial Do... | 18 Years - | Weill Medical College of Cornell University | |
| Optimizing Positive Predicting Value of Prostate MRI | NCT05078359 | Prostate Cancer | Prostate Magnet... | 18 Years - 80 Years | Ospedali Riuniti di Foggia | |
| Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients. | NCT04367779 | Brain Cancer Meningioma Sarcoma | - | Centre Leon Berard | ||
| Physical Activity Monitoring in Myasthenia Gravis | NCT06277830 | Myasthenia Grav... | Wearable sensor | 18 Years - 80 Years | Massachusetts General Hospital | |
| The Fibrosis-Lymphedema Continuum in Head and Neck Cancer | NCT01187173 | Head and Neck N... Fibrosis Lymphedema Biomarkers Polymorphism, G... Depression | 21 Years - | Vanderbilt University | ||
| Molecular Biomarkers Predicting Early Development of Endometrial Carcinoma | NCT05273099 | Cancer of Endom... | 18 Years - | Università degli Studi di Ferrara | ||
| Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease | NCT01784549 | Non Small Cell ... | Cisplatin Docet... | 18 Years - | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | |
| Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers | NCT00001693 | Colorectal Neop... Hereditary Nonp... | Celecoxib (SC-5... | - | National Institutes of Health Clinical Center (CC) | |
| Dynamic PET CT as a Tool for Treatment Efficacy Monitoring in Lung Cancer | NCT02505685 | Lung Cancer | 18 Years - 95 Years | Rabin Medical Center | ||
| Tivozanib in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer | NCT01745367 | Triple Negative... | Tivozanib Hydro... paclitaxel Placebo | 18 Years - | AVEO Pharmaceuticals, Inc. | |
| Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines | NCT03155802 | Cardiotoxicity Heart Failure Breast Cancer Anthracycline I... Biomarkers Echocardiograph... | 18 Years - 85 Years | Stony Brook University | ||
| An European Platform for Translational Research in Myelodysplastic Syndromes | NCT04174547 | Myelodysplastic... | 18 Years - | Istituto Clinico Humanitas | ||
| Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment. | NCT05507034 | Neoplasm, Breas... Carcinoma Breas... Chronic Pain | Biomarkers | 25 Years - 65 Years | Universiteit Antwerpen | |
| Immunophenotyping of Melanoma Patients on Treatment With Pembrolizumab | NCT02909348 | Neoplasms Melanoma | Pembrolizumab | 18 Years - | Royal Free Hospital NHS Foundation Trust | |
| PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Acetate. | NCT02787837 | Advanced Prosta... Abiraterone ACe... | 18 Years - 99 Years | Centro Nacional de Investigaciones Oncologicas CARLOS III | ||
| Impact of Exercise on Prognostic Biomarkers Related to Prostate Cancer | NCT03397030 | Prostatic Neopl... | Home-Based Exer... | 40 Years - | The University of Texas Health Science Center at San Antonio | |
| Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma | NCT01339975 | Carcinoma Carcinoma Renal... Kidney Neoplasm... Kidney Diseases Chemokines | Biological samp... Biological samp... | 18 Years - | University Hospital, Bordeaux | |
| SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access | NCT02307604 | Brain Neoplasms | Tumour markers ... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Collaborative Study of 1,3 Butadiene Biomarkers | NCT00023140 | Cancer | 19 Years - 65 Years | National Institute of Environmental Health Sciences (NIEHS) | ||
| Evaluation of Peripheral Blood Protein Biomarkers for Colorectal Cancer Screening | NCT05520840 | Colorectal Canc... | blood sampling ... | 50 Years - | University Hospital, Rouen | |
| Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting | NCT03912883 | Prostate Cancer | 18 Years - 76 Years | Queen Mary University of London | ||
| Molecular Staging of Endometrial Cancer | NCT00340808 | Endometrial Can... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer | NCT06235853 | Non-muscle Inva... Cystoscopy Recurrence Progression Bladder Cancer Biomarkers | Blood serum: sU... Urine: IL-8, AP... | 18 Years - | Wroclaw Medical University | |
| Early Detection of Breast Cancer in Women With Suspicious Mammograms | NCT03147430 | Breast Cancer | Biomarkers | 18 Years - | Sentara Norfolk General Hospital | |
| Impact of COVID-19 on GU Disease | NCT04761107 | COVID-19 Infect... Genitourinary C... Benign Urologic... | 40 Years - | Icahn School of Medicine at Mount Sinai | ||
| A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the Disease | NCT01933022 | Metastatic Pros... | Eligard | 18 Years - | Astellas Pharma Inc | |
| BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC") | NCT03311776 | Pancreatic Canc... | 19 Years - | Herlev Hospital | ||
| Study of Sunitinib in Subjects With High Risk Renal Cell Carcinoma | NCT01070186 | Renal Cell Carc... | Sunitinib Tumor biopsy Nephrectomy Biomarkers | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Urine Omics Predicting IO Therapy Responses in mRCC Patients | NCT04712305 | Metastatic Rena... | No intervention... | 20 Years - | National Taiwan University Hospital | |
| Correlative Biomarker Study in Patients With Myeloproliferative Disorders | NCT00665067 | Myeloproliferat... Myelofibrosis Idiopathic Myel... Essential Throm... Polycythemia Ve... | 18 Years - | Icahn School of Medicine at Mount Sinai | ||
| Proteomics in Small Cell Lung Cancer | NCT05623956 | Small Cell Lung... | 18 Years - | Aalborg University Hospital | ||
| Clinical Evaluation of a New Cancer Diagnosis Center at Kristianstad General Hospital, Sweden | NCT01709539 | Cancer | Diagnostiskt Ce... | 18 Years - | Region Skane | |
| Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated With Imiquimod | NCT06356012 | HSIL, High-Grad... Vaginal Microbi... Biomarkers | Imiquimod Loop Electrosur... | 25 Years - 45 Years | Barretos Cancer Hospital | |
| Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors | NCT01081808 | Neoplasms Tumors Solid Tumors Metastatic Canc... | EGFRBi-armed au... | 18 Years - | Roger Williams Medical Center | |
| Collaborative Study of 1,3 Butadiene Biomarkers | NCT00023140 | Cancer | 19 Years - 65 Years | National Institute of Environmental Health Sciences (NIEHS) | ||
| Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy | NCT01848457 | Osteosarcoma Nephrotoxicity Ototoxicity | Pantoprazole High-dose metho... | - 30 Years | Children's Hospital of Philadelphia | |
| Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer | NCT00805688 | Pancreatic Canc... | Questionnaires Blood Draws Pedometer | 18 Years - | M.D. Anderson Cancer Center | |
| A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers | NCT02272504 | Cirrhosis Chronic Liver D... | 18 Years - | Wako Life Sciences | ||
| A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat | NCT02890069 | Colorectal Canc... | PDR001 LCL161 Everolimus Panobinostat QBM076 HDM201 | 18 Years - | Novartis | |
| Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification | NCT01839045 | Breast Cancer | 25 Years - 49 Years | Provista Diagnostics, Inc | ||
| Observational Study on Biomarkers in Head and Neck Cancer (HNprädBio) | NCT02059668 | Head and Neck C... | Biomarker analy... | 18 Years - | Technische Universität Dresden | |
| Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET) | NCT03053999 | Multiple Endocr... Pancreatic Neur... Hyperparathyroi... | Genome Sequenci... Data Review | - | M.D. Anderson Cancer Center | |
| Susceptibility to Breast Cancer | NCT00004565 | Breast Cancer Healthy | - | National Institutes of Health Clinical Center (CC) | ||
| Urinary Biomarker Study With Sulindac and Difluoromethylornithine | NCT01636128 | Focus of Study:... | difluoromethylo... Sulindac | 40 Years - 65 Years | Cancer Prevention Pharmaceuticals, Inc. | |
| Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS) | NCT03148015 | Breast Cancer | Biomarkers | 18 Years - | Sentara Norfolk General Hospital | |
| Study of Olaparib (± Degarelix) Given to Men With Intermediate/High Risk Prostate Cancer Before Prostatectomy | NCT02324998 | Prostate Cancer | Olaparib Degarelix | 18 Years - 73 Years | Cambridge University Hospitals NHS Foundation Trust | |
| Well-being Biomarkers (BIOSMILE) & Psychology Analyses in Women With Cancer After Hospital Clowns and Hosting Effects | NCT06143189 | Well-Being, Psy... Biomarkers Cancer Ambulatory Care Complementary T... | Hosting conditi... Hospital Clowns | 18 Years - | University of Coimbra | |
| High-Intensity Interval Training for Women at Heightened Risk for Breast Cancer | NCT02923401 | Disorders of Br... | Exercise Questionnaires Motivational Se... Phone Call Printed Materia... | 18 Years - 55 Years | M.D. Anderson Cancer Center | |
| A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer | NCT02450539 | Non-Small Cell ... | Abemaciclib Docetaxel | 18 Years - | Eli Lilly and Company | |
| Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC | NCT01767779 | Tuberous Sclero... | 1 Day - 6 Months | University of Alabama at Birmingham | ||
| Correlative Biomarker Study in Patients With Myeloproliferative Disorders | NCT00665067 | Myeloproliferat... Myelofibrosis Idiopathic Myel... Essential Throm... Polycythemia Ve... | 18 Years - | Icahn School of Medicine at Mount Sinai | ||
| The Natural History of Solid Organ Cancer Stem Cells (SOCSC) | NCT00923052 | Hepatic Cancer Pancreatic Duct... Colorectal Canc... Breast Cancer Gastric Cancer | 16 Years - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| Biomarker Development in Sturge-Weber Syndrome | NCT01345305 | Sturge-Weber Sy... | 6 Months - 21 Years | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | ||
| Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate | NCT02944201 | Prostate Cancer | Carvedilol | 18 Years - | Montefiore Medical Center | |
| Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting | NCT03912883 | Prostate Cancer | 18 Years - 76 Years | Queen Mary University of London | ||
| A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat | NCT02890069 | Colorectal Canc... | PDR001 LCL161 Everolimus Panobinostat QBM076 HDM201 | 18 Years - | Novartis | |
| Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective Study | NCT02247453 | Lung Cancer | screening | 50 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer | NCT03260842 | Pancreatic Cyst Pancreas Diseas... | Bio-Specimen Co... | 18 Years - | Stanford University | |
| Susceptibility to Breast Cancer | NCT00004565 | Breast Cancer Healthy | - | National Institutes of Health Clinical Center (CC) | ||
| Breast Cancer, Omics, and Precision Medicine | NCT04996836 | Breast Cancer | Next Generation... | 18 Years - | University of Campania "Luigi Vanvitelli" | |
| Retrospective Observational Study on Prediction of Response to PD-1 Immunotherapy in Patients With NSCLC | NCT04886401 | Advanced Non Sm... | - | University Hospital, Brest | ||
| Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients | NCT04340024 | Nasopharyngeal ... Prostate Cancer Other Cancer | 21 Years - 99 Years | National Cancer Centre, Singapore | ||
| Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations | NCT05687188 | Pancreatic Canc... | Blood Sample Co... Tissue Sample C... Data Collection Medical Image C... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Chemoprevention of Colorectal Cancer: the Role of Non-digestible Carbohydrates | NCT01214681 | Colorectal Canc... | Maltodextrin an... Hi-maize 260 Polydextrose Hi-maize 260 an... | 16 Years - 85 Years | Newcastle University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
